Search

Your search keyword '"Bober AS"' showing total 551 results

Search Constraints

Start Over You searched for: Author "Bober AS" Remove constraint Author: "Bober AS" Publisher elsevier bv Remove constraint Publisher: elsevier bv
551 results on '"Bober AS"'

Search Results

3. Randomized Trial of a Multimodal Intervention to Enhance Sexual Function and Quality of Life (QOL) in Hematopoietic Stem Cell Transplant (HSCT) Survivors

5. Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial

8. RAB1A haploinsufficiency phenocopies the 2p14–p15 microdeletion and is associated with impaired neuronal differentiation

10. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline ☆

13. Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trial

15. Identification of potential non-invasive biomarkers in diastrophic dysplasia

16. Route of delivery does not impact postnatal surgical morbidity in pregnancies affected by fetal achondroplasia

18. Findings from the Morquio A Registry Study (MARS) after 6 years: Long-term outcomes of MPS IVA patients treated with elosulfase alfa

19. The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program

24. Impact of delivery route on postnatal surgical morbidity in fetal achondroplasia: a multicenter cohort study

26. O22: A randomized controlled trial of vosoritide in infants and toddlers with achondroplasia*

28. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

29. P339: Vosoritide therapy in patients with achondroplasia: Early experience and practical considerations for clinical practice

30. P193: Persistent growth-promoting effects of vosoritide in children with achondroplasia for up to 3.5 years: Update from phase 3 extension study*

31. Multidisciplinary Care of Neurosurgical Patients with Genetic Syndromes

32. Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study

36. Incorporating the Principles of Sex Therapy into Urologic Care

37. Mapping of initial conditions for libration point orbits

40. Findings from the Morquio A Registry Study (MARS) after 6 years: Long-term outcomes of MPS IVA patients treated with elosulfase alfa

44. The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program

45. Macroporous nitrogen-containing carbon for electrochemical capacitors

48. Facile preparation of water-dispersible carboxylated polyaniline

50. Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study.

Catalog

Books, media, physical & digital resources